AGR2 was highly overexpressed in our previous integrated proteomic analysis of cell lines and pancreatic juice as well, and our preliminary verification studies showed it to be significantly elevated in plasma from pancreatic cancer patients [13]. The gene discussed is AGR2; the disease is pancreatic neoplasm.